title: Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine.
abstract: Cancer remains one of the leading causes of mortality and morbidity throughout the world. To a significant extent, current conventional cancer therapies are symptomatic and passive in nature. The major obstacle to the development of effective cancer therapy is believed to be the absence of sufficient specificity. Since the discovery of the tumor-oriented homing capacity of mesenchymal stem cells (MSCs), the application of specific anticancer gene-engineered MSCs has held great potential for cancer therapies. The dual-targeted strategy is based on MSCs' capacity of tumor-directed migration and incorporation and in situ expression of tumor-specific anticancer genes. With the aim of translating bench work into meaningful clinical applications, we describe the tumor tropism of MSCs and their use as therapeutic vehicles, the dual-targeted anticancer potential of engineered MSCs and a putative personalized strategy with anticancer gene-engineered MSCs.
authors.affiliation: Xu-Yong Sun, Jiang Nong, Ke Qin, Institute of Transplant Medicine, 303 Hospital of Chinese People's Liberation Army, Nanning 530021, The Guangxi Zhuang Autonomous Region, China.
authors.forename: Xu-Yong
authors.initials: XY
authors.lastname: Sun
authors.forename: Jiang
authors.initials: J
authors.lastname: Nong
authors.forename: Ke
authors.initials: K
authors.lastname: Qin
authors.forename: Garth L
authors.initials: GL
authors.lastname: Warnock
authors.forename: Long-Jun
authors.initials: LJ
authors.lastname: Dai